Citigroup assumed coverage on shares of Cerner (NASDAQ:CERN) in a report issued on Thursday, January 4th, The Fly reports. The brokerage issued a neutral rating on the stock.

Several other equities research analysts also recently commented on CERN. Robert W. Baird reaffirmed a buy rating on shares of Cerner in a report on Wednesday, January 3rd. Zacks Investment Research raised Cerner from a sell rating to a hold rating in a research note on Tuesday, December 26th. BidaskClub lowered Cerner from a buy rating to a hold rating in a research report on Friday, December 22nd. Cantor Fitzgerald reaffirmed a buy rating and issued a $75.00 target price on shares of Cerner in a research report on Wednesday, November 29th. Finally, Piper Jaffray Companies reaffirmed a buy rating and issued a $70.00 target price on shares of Cerner in a research report on Thursday, November 30th. One research analyst has rated the stock with a sell rating, sixteen have given a hold rating and eight have given a buy rating to the company. The stock has an average rating of Hold and a consensus price target of $70.21.

Shares of Cerner (NASDAQ CERN) opened at $68.73 on Thursday. Cerner has a twelve month low of $51.26 and a twelve month high of $73.86. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.77 and a quick ratio of 2.75. The firm has a market capitalization of $22,803.66, a P/E ratio of 30.35, a PEG ratio of 2.04 and a beta of 0.94.

Cerner (NASDAQ:CERN) last issued its quarterly earnings data on Thursday, October 26th. The company reported $0.61 EPS for the quarter, missing the Zacks’ consensus estimate of $0.62 by ($0.01). The company had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.29 billion. Cerner had a return on equity of 18.03% and a net margin of 13.37%. Cerner’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.59 earnings per share. sell-side analysts predict that Cerner will post 2.24 earnings per share for the current fiscal year.

In other Cerner news, CEO Clifford W. Illig sold 140,000 shares of the business’s stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $65.52, for a total transaction of $9,172,800.00. Following the transaction, the chief executive officer now owns 1,229,719 shares of the company’s stock, valued at $80,571,188.88. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Marc G. Naughton sold 60,000 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $70.64, for a total value of $4,238,400.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 788,000 shares of company stock worth $52,190,800. Corporate insiders own 13.11% of the company’s stock.

Several hedge funds have recently modified their holdings of CERN. Advisory Services Network LLC lifted its stake in shares of Cerner by 4.4% in the 2nd quarter. Advisory Services Network LLC now owns 1,648 shares of the company’s stock valued at $110,000 after acquiring an additional 70 shares during the last quarter. Acrospire Investment Management LLC lifted its position in Cerner by 100.0% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,800 shares of the company’s stock valued at $120,000 after acquiring an additional 900 shares in the last quarter. Fuller & Thaler Asset Management Inc. bought a new position in Cerner in the 3rd quarter valued at about $121,000. Cerebellum GP LLC bought a new position in shares of Cerner during the 4th quarter worth approximately $127,000. Finally, Steward Partners Investment Advisory LLC bought a new position in shares of Cerner during the 3rd quarter worth approximately $128,000. Institutional investors and hedge funds own 81.92% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This article was originally published by Marea Informative and is the sole property of of Marea Informative. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://www.mareainformativa.com/2018/01/30/cerner-cern-earns-neutral-rating-from-analysts-at-citigroup-updated-updated-updated.html.

Cerner Company Profile

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

The Fly

Analyst Recommendations for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.